OXURION NV (OXUR.BR) Stock Price, Quote, News and Overview
EBR:OXUR - Euronext Brussels - BE0974487192 - Common Stock - Currency: EUR
OXUR.BR Quote, Performance and Key Statistics
EBR:OXUR (3/7/2025, 7:00:00 PM)
0.185
-0.01 (-5.13%)
The current stock price of OXUR.BR is 0.185 EUR. In the past month the price decreased by -22.27%. In the past year, price increased by 92400%.
OXUR.BR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 21.07 | 346.68B | ||
| 1ABBV.MI | ABBVIE INC | 20.82 | 342.48B | ||
| AMG.DE | AMGEN INC | 16.43 | 161.21B | ||
| 1AMGN.MI | AMGEN INC | 15.84 | 160.89B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 25.67 | 135.84B | ||
| GIS.DE | GILEAD SCIENCES INC | 25.39 | 134.40B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1667.04 | 115.58B | ||
| ARGX.BR | ARGENX SE | 253.61 | 33.75B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 24.36B | ||
| IDP.DE | BIOGEN INC | 9.25 | 20.54B | ||
| 1BIIB.MI | BIOGEN INC | 8.39 | 19.21B | ||
| 0QF.DE | MODERNA INC | N/A | 13.19B |
Related stock screener links
About OXUR.BR
Company Profile
Oxurion NV is a BE-based company operating in Biotechnology industry. The company is headquartered in Leuven (Louvain), Vlaams-Brabant and currently employs 20 full-time employees. The company went IPO on 2006-07-07. Oxurion NV, formerly known as ThromboGenics NV, is a Belgium-based biopharmaceutical company, which focuses on the development and commercialization of ophthalmic medicines. Its lead product, JETREA (ocriplasmin), has been approved by the United States Food and Drug Administration for the treatment of symptomatic vitreomacular adhesion (VMA) and was launched in January 2013. Oxurion partners with Alcon (Novartis) for the commercialization of JETREA outside the United States. In Europe, JETREA is approved for the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns, which was launched in the United Kingdom and Germany. In addition, it also explores anti-PIGF (Placental Growth Factor), also referred to as TB-403, for the treatment of ophthalmic and oncology indications. The firm is active domestically, as well as operates through offices located in the United States and Ireland.
Company Info
OXURION NV
Gaston Geenslaan 1
LEUVEN (LOUVAIN) VLAAMS-BRABANT BE
Employees: 20
Company Website: https://www.oxurion.com
Investor Relations: http://ir.oxurion.com
Phone: 3216751310
OXURION NV / OXUR.BR FAQ
What is the stock price of OXURION NV today?
The current stock price of OXUR.BR is 0.185 EUR. The price decreased by -5.13% in the last trading session.
What is the ticker symbol for OXURION NV stock?
The exchange symbol of OXURION NV is OXUR and it is listed on the Euronext Brussels exchange.
On which exchange is OXUR.BR stock listed?
OXUR.BR stock is listed on the Euronext Brussels exchange.
What is OXURION NV worth?
OXURION NV (OXUR.BR) has a market capitalization of 673.40K EUR. This makes OXUR.BR a Nano Cap stock.
How many employees does OXURION NV have?
OXURION NV (OXUR.BR) currently has 20 employees.
What are the support and resistance levels for OXURION NV (OXUR.BR) stock?
OXURION NV (OXUR.BR) has a resistance level at 0.2. Check the full technical report for a detailed analysis of OXUR.BR support and resistance levels.
Should I buy OXURION NV (OXUR.BR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OXUR.BR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OXUR.BR, evaluating the profitability, health, valuation and growth aspects
- OXURION NV (OXUR.BR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OXURION NV (OXUR.BR) Sales and EPS estimates to see what analysts future expectations are.
- OXURION NV (OXUR.BR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OXURION NV (OXUR.BR) Insider and Institutional Ownership to learn about the owners and their transactions.
- OXURION NV (OXUR.BR) Stock Chart to make your own analysis
- OXURION NV (OXUR.BR) Latest news and press-releases to stay up to date.
Does OXURION NV (OXUR.BR) stock pay dividends?
OXUR.BR does not pay a dividend.
What is the Price/Earnings (PE) ratio of OXURION NV (OXUR.BR)?
OXURION NV (OXUR.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-32.56).
OXUR.BR Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to OXUR.BR. When comparing the yearly performance of all stocks, OXUR.BR is one of the better performing stocks in the market, outperforming 99.98% of all stocks.
OXUR.BR Financial Highlights
Over the last trailing twelve months OXUR.BR reported a non-GAAP Earnings per Share(EPS) of -32.56. The EPS increased by 98.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -249.85% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OXUR.BR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 42% to OXUR.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.